USPTO serial 97978199
ORA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 16, 2025
- Examiner
- YOUNG, THOMAS PAUL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ORA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Zhubei, Hsinchu County, TW
Zhubei, Hsinchu County, TW
Zhubei, Hsinchu County, TW
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Chinhwei Chen
Chinhwei Chen Jianq Chyun Intellectual Property Office7F. -1, No. 100, Roosevelt Rd. Sec. 2TAIPEI, 10084TAIWANGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Bacterial preparations other than for medical and veterinary use; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Industrial chemicals; Biological preparations for use in industry and science, not for medical or veterinary purposes; Chemical preparations for scientific purposes, other than for medical or veterinary use; Cultures of microorganisms, other than for medical and veterinary use; Chemicals for use in science; Nucleic acid amplification reagents for scientific and research use, not for medical use; Reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA) for scientific and research use, not for medical or veterinary purposes; Chemical reagents for genetic identity testing, not for medical purposes; Chemical reagents for use in diagnostic tests, other than for medical or veterinary use; Chemical reagents for use in analytical tests, other than for medical or veterinary use; Chemical reagents for non-medical purposes; Enzymes for detecting proteins for scientific purposes, other than for medical use; Biochemical testing reagents other than for medical purposes; Chemical reagents for laboratory use, other than for medical or veterinary use; Chemical reagents for use in genetic research; Chemical reagents for genetic identity testing, for research purposes; Testing reagents for scientific use; Kits comprising chemicals for use in industry for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and biological and biochemical sample material, namely, industrial chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification, sequencing and analysis, not for medical purposes; Clinical diagnostic reagents for scientific or research use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, for scientific use; Chemical, biochemical and biotechnological products for commercial and scientific use, namely, buffer solutions, nucleic acids, nucleic acid derivatives and proteins for chemical analysis, not for medical or veterinary purposes | ACTIVE | Oct 19, 2024 |
| 005 | Enzyme preparations for medical purposes; Bacterial preparations for medical purposes; Medical diagnostic assays for testing of bodily fluids and tissue in the detection, monitoring, and prediction of disease or other conditions, disease states, hormone level, drug level, drug response, organ function effectiveness, and clinical response; Reagents for use in diagnostic tests for medical purposes; Diagnostic biomarker reagents for medical purposes; Reagent paper for medical purposes; Clinical diagnostic reagents for medical use; Chemical test reagents for medical use; Chemical reagents, namely, diagnostic medical reagent strips for use by individuals to test their own body fluids and for use by the medical profession; Reagents for use in medical genetic testing; Genetic identity tests comprised of reagents for medical purposes; Medical diagnostic reagents and assays for testing of body fluids; Nucleic acid sequences and chemical reagents for medical purposes | ACTIVE | Oct 19, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 16, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 16, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 3, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 28, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 12, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 19, 2025 | IUAF | USE AMENDMENT FILED | — |
| Feb 19, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 3, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 19, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 6, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 5, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 5, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 5, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 5, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 8, 2024 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| May 7, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 11, 2024 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Apr 11, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 11, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 11, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 11, 2024 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jan 18, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 16, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 24, 2023 | NWAP | NEW APPLICATION ENTERED | — |